Discover how the 340B drug pricing program, intended to help low-income patients, has become a system of abuse and misuse ...

WELCOME BACK: Drugmakers’ top lobbying group is welcoming lawmakers back to town this week with a seven-figure ad blitz, ramping up pressure on Congress to enact a crackdown on pharmaceutical ...

PhRMA is pushing to get pharmacy benefit manager (PBM) reform over the line in Congress’ lame-duck session, using its first ...

Johnson & Johnson seeks to charge 340B-enrolled disproportionate share hospitals full price for Xarelto and Stelara and issue ...

The US trade group Pharmaceutical Research and Manufacturers of America (PhRMA) today launched new advertisements urging ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story PBM reform push heats up Congress is ...

Founded and led by Obama campaign veterans, Bully Pulpit Interactive (BPI) has been a leading Democratic consultancy and ...

In total, there are 81 therapies in clinical development, with 16 in phase III and II/III of clinical trials according to ...

Legal challenges to Medicare’s price negotiation initiative introduced in the Inflation Reduction Act (IRA) continue to emerge, with pharmaceutical trade organisation PhRMA joining the fray ...

On Tuesday night, millions of Americans watched as former president Donald J. Trump gathered up enough electoral votes needed ...

More than half of insured Americans say they can't predict how much their covered prescription drugs will cost, according to ...

LAS VEGAS — Executives from healthcare organizations as varied as Amazon’s online pharmacy, retailer Walgreens, insurer Blue Shield of California and drugmaker lobby PhRMA called for an end ...